Document is current
Any future updates will be listed below
-
Authors
Fowle-Grider, Ronald
Rowles, Joe L. III
Shen, Isabel
Wang, Yahui
Schwaiger-Haber, Michaela https://orcid.org/0000-0002-2715-753X
Dunham, Alden J. https://orcid.org/0000-0001-5044-517X
Jayachandran, Kay
Inkman, Matthew https://orcid.org/0000-0001-5490-2374
Zahner, Michael
Naser, Fuad J.
Jackstadt, Madelyn M. https://orcid.org/0000-0001-5520-9213
Spalding, Jonathan L.
Chiang, Sarah
McCommis, Kyle S. https://orcid.org/0000-0003-2381-1589
Dolle, Roland E. https://orcid.org/0000-0001-5574-6019
Kramer, Eva T. https://orcid.org/0000-0003-1363-3125
Zimmerman, Sarah M.
Souroullas, George P. https://orcid.org/0000-0003-2196-8662
Finck, Brian N. https://orcid.org/0000-0001-5411-3674
Shriver, Leah P.
Kaufman, Charles K. https://orcid.org/0000-0003-3122-1677
Schwarz, Julie K. https://orcid.org/0000-0003-2407-7531
Zhang, Jin https://orcid.org/0000-0002-9117-2793
Patti, Gary J. https://orcid.org/0000-0002-3748-6193
- License Information
-
More Information
Article History
Received: 18 June 2020
Accepted: 21 October 2024
First Online: 4 December 2024
Competing interests
: B.N.F. is a stockholder and member of the scientific advisory board of Cirius Therapeutics. G.J.P. is a scientific advisory board member for Cambridge Isotope Laboratories and has a collaborative research agreement with Agilent Technologies. G.J.P. is the Chief Scientific Officer of Panome Bio.
